FIELD: medicine; sphere of biochemical studies. SUBSTANCE: essence o/f this method resides in that blood is tested for content of iron-dependent, organic-compound-containing and antibody-like RF proteins showing false TFD-activity, having immunocamouflaging properties and mandatorily entering humoral medium, against background of reduction of content of vitamins A and E by 50 % and more and sequential suppression of activity of antioxidant enzymes. EFFECT: higher accuracy of diagnosing oncological diseases and revealing conditions that favor initiation of carcinoma; revelation of level of RF-proteins in humoral medium serves as means of differentially diagnosing malignant process; analysis of biochemical medium parameters offers new approaches to diagnosing, treating and prognosticating effectiveness of selected therapeutic methods; nonexpensiveness and simplicity.
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR DIAGNOSTICS OF CANCER RELAPSES AND METASTASES | 1993 | 
 | RU2082984C1 | 
| METHOD FOR PREDICTING COMPLICATIONS OCCURRENCE IN PERFORMING ANTITUMOR TREATMENT | 1995 | 
 | RU2107918C1 | 
| METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS | 1999 | 
 | RU2170433C2 | 
| METHOD FOR PREPARING UTERINE NECK CARCINOMA PATIENTS OF THE III STAGE FOR MAKING OPERATION | 1996 | 
 | RU2149661C1 | 
| METHOD FOR DIAGNOSING PRIMARY FOCUS OF MALIGNANT TUMOR | 1998 | 
 | RU2146057C1 | 
| METHOD OF DETERMINATION OF ANTITUMORIGENIC THERAPY EFFECTIVENESS | 1991 | 
 | RU2021620C1 | 
| METHOD FOR PREDICTING HEMANGIOMA TREATMENT EFFICIENCY | 2004 | 
 | RU2268469C2 | 
| METHOD FOR APPLYING PROLONGED PHARMACOTHERAPY | 2003 | 
 | RU2271833C2 | 
| METHOD FOR TREATING RELAPSES OF UTERINE CERVIX CANCER | 2003 | 
 | RU2243766C1 | 
| THERAPY OF LOCALLY ADVANCED NONRESECTABLE RECTAL CANCER | 2007 | 
 | RU2360712C1 | 
Authors
Dates
1994-10-15—Published
1991-08-27—Filed